| abstract |
The present invention provides a novel human-derived prostaglandin D 2 synthase inhibitor. SOLUTION: 1-amino-4- (4-sulfamoylanilino) -anthraquinone-2-sulfonic acid (a water-soluble red dye), 2- (2'-benzothiazolyl) -5-styryl-3- ( human prostaglandin D 2 synthase inhibitors and 4'-phthalic hydrazinium dill) tetrazolium chloride as an active ingredient. In addition, it can regulate the physiological effects of sleep, body temperature, estrous cycle, analgesia or smell. [Selection diagram] None |